Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension See Editorial on Page 1434
dc.contributor.author | de Franchis, Roberto | en_US |
dc.contributor.author | Eisen, Glenn M. | en_US |
dc.contributor.author | Laine, Loren | en_US |
dc.contributor.author | Fernandez-Urien, Inaki | en_US |
dc.contributor.author | Herrerias, Juan Manuel | en_US |
dc.contributor.author | Brown, Russell D. | en_US |
dc.contributor.author | Fisher, Laurel | en_US |
dc.contributor.author | Vargas, Hugo E. | en_US |
dc.contributor.author | Vargo, John | en_US |
dc.contributor.author | Thompson, Julie | en_US |
dc.contributor.author | Eliakim, Rami | en_US |
dc.date.accessioned | 2008-05-12T13:37:15Z | |
dc.date.available | 2009-05-04T19:09:21Z | en_US |
dc.date.issued | 2008-05 | en_US |
dc.identifier.citation | de Franchis, Roberto; Eisen, Glenn M.; Laine, Loren; Fernandez-Urien, Inaki; Herrerias, Juan Manuel; Brown, Russell D.; Fisher, Laurel; Vargas, Hugo E.; Vargo, John; Thompson, Julie; Eliakim, Rami (2008). "Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension See Editorial on Page 1434 ." Hepatology 47(5): 1595-1603. <http://hdl.handle.net/2027.42/58562> | en_US |
dc.identifier.issn | 0270-9139 | en_US |
dc.identifier.issn | 1527-3350 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/58562 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=18435461&dopt=citation | |
dc.description.abstract | Bleeding from esophageal varices (EV) is a serious consequence of portal hypertension. Current guidelines recommend screening patients with cirrhosis with esophagogastroduodenoscopy (EGD) to detect varices. However, the unpleasantness and need for sedation of EGD may limit adherence to screening programs. Pilot studies have shown good performance of esophageal capsule endoscopy in detecting varices. This multicenter trial was designed to assess the diagnostic performance of capsule endoscopy in comparison with EGD. Patients undergoing EGD for screening or surveillance of EV underwent a capsule study previously. The study was designed as an equivalence study, assuming that a difference of ≤10% between capsule endoscopy and EGD in diagnosing EV would demonstrate equivalence. Two hundred eighty-eight patients were enrolled. Endoscopy was for screening in 195 patients and for surveillance of known EV in 93. Overall agreement for detecting EV between EGD and capsule endoscopy was 85.8%; the kappa score was 0.73. Capsule endoscopy had a sensitivity, specificity, positive predictive value, and negative predictive value of 84%, 88%, 92%, and 77%, respectively. The difference in diagnosing EV was 15.6% in favor of EGD. There was complete agreement on variceal grade in 227 of 288 cases (79%). In differentiating between medium/large varices requiring treatment and small/absent varices requiring surveillance, the sensitivity, specificity, positive predictive value, and negative predictive value for capsule endoscopy were 78%, 96%, 87%, and 92%, respectively. Overall agreement on treatment decisions based on EV size was substantial at 91% (kappa = 0.77). Conclusion: We recommend that EGD be used to screen patients with cirrhosis for large EV. However, the minimal invasiveness, good tolerance, and good agreement of capsule endoscopy with EGD might increase adherence to screening programs. Whether this is the case needs to be determined. (H EPATOLOGY 2008;47:1595–1603.) | en_US |
dc.format.extent | 664552 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Wiley Subscription Services, Inc., A Wiley Company | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Hepatology | en_US |
dc.title | Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension See Editorial on Page 1434 | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationother | Department of Medical Sciences, University of Milan, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Ospedale Maggiore Policlinico, Mangiagalli and Regina Elena, Milan, Italy ; Potential conflict of interest: Drs. de Franchis, Eliakim, and Eisen are consultants for and received grants from Given Imaging. Dr. Laine received grants from Given Imaging. Dr. Brown is on the speakers' bureau of Given Imaging. Dr. Fischer is a consultant for and is on the speakers' bureau of Given Imaging. Dr. Vargas received grants from Roche, Novartis, Vertex, Idenix, Pharmasset, Debiopharm, and Given Imaging. ; fax: (39) 025 032 0747 ; Department of Medical Sciences, University of Milan, Istituto di Ricovero e Cura a Carattere Scientifico Fondazione Ospedale Maggiore Policlinico, Mangiagalli and Regina Elena, Milan, Italy | en_US |
dc.contributor.affiliationother | Oregon Health Sciences University, Portland, OR | en_US |
dc.contributor.affiliationother | University of Southern California, Los Angeles, CA | en_US |
dc.contributor.affiliationother | Universidad de Navarra, Pamplona, Spain | en_US |
dc.contributor.affiliationother | Hospital Universitario Virgen Macarena, Seville, Spain | en_US |
dc.contributor.affiliationother | University of Illinois at Chicago, Chicago, IL | en_US |
dc.contributor.affiliationother | Mayo Clinic Foundation, Scottsdale, AZ | en_US |
dc.contributor.affiliationother | Cleveland Clinic Foundation, Cleveland, OH | en_US |
dc.contributor.affiliationother | University of Minnesota, Minneapolis, MN | en_US |
dc.contributor.affiliationother | Rambam Medical Center, Haifa, Israel | en_US |
dc.identifier.pmid | 18435461 | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/58562/1/22227_ftp.pdf | |
dc.identifier.doi | http://dx.doi.org/10.1002/hep.22227 | en_US |
dc.identifier.source | Hepatology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.